CRE26-049: Intrathecal Rituximab for Central Nervous System Involvement in Chronic Lymphocytic Leukemia: Case Report and Literature Review
Journal of the National Comprehensive Cancer Network · 31.03.2026 · 24 (3.5)
DOI: 10.6004/jnccn.2025.7149 ↗Kurz gefasst
Fallbericht in der Zeitschrift Journal of the National Comprehensive Cancer Network, erschienen am 31.03.2026. Verfasst von Aashima Gupta und 2 weiteren Autor:innen. Beteiligte Einrichtung: 1Department of Internal Medicine, St. Luke's University Health Network, Bethlehem, PA.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Autor:innen und Institutionen
- 1Department of Internal Medicine, St. Luke's University Health Network, Bethlehem, PA.
- 2Department of Hematology and Oncology, St. Luke's University Health Network, Bethlehem, PA.
Zitieren
APA
Gupta, A., Aiad, M., & Faroun, Y. (2026). CRE26-049: Intrathecal Rituximab for Central Nervous System Involvement in Chronic Lymphocytic Leukemia: Case Report and Literature Review. Journal of the National Comprehensive Cancer Network, 24(3.5). https://doi.org/10.6004/jnccn.2025.7149
Vancouver
Gupta A, Aiad M, Faroun Y. CRE26-049: Intrathecal Rituximab for Central Nervous System Involvement in Chronic Lymphocytic Leukemia: Case Report and Literature Review. Journal of the National Comprehensive Cancer Network. 2026;24(3.5). doi:10.6004/jnccn.2025.7149
BibTeX
@article{Gupta2026,
author = {Gupta, Aashima and Aiad, Mina and Faroun, Yacoub},
title = {CRE26-049: Intrathecal Rituximab for Central Nervous System Involvement in Chronic Lymphocytic Leukemia: Case Report and Literature Review},
journal = {Journal of the National Comprehensive Cancer Network},
year = {2026},
volume = {24},
number = {3.5},
doi = {10.6004/jnccn.2025.7149}
}
EUVIMED